LIVAZO 4MG 28 TAB

LIVAZO 4 mg Tablets (28 tablets)

Active Ingredient:
Pitavastatin Calcium (equivalent to Pitavastatin 4 mg)

Therapeutic Class:
Lipid-Lowering Agent – HMG-CoA Reductase Inhibitor (Statin)

Indications:
LIVAZO is indicated for:

• Treatment of primary hyperlipidemia and mixed dyslipidemia

• Reducing elevated total cholesterol, LDL-C (low-density lipoprotein cholesterol), and triglycerides

• Increasing HDL-C (high-density lipoprotein cholesterol)

• Reducing cardiovascular risk in patients with risk factors such as type 2 diabetes or existing coronary heart disease

Mechanism of Action:
Pitavastatin inhibits HMG-CoA reductase, the key enzyme in hepatic cholesterol biosynthesis. This results in reduced cholesterol production and increased clearance of LDL cholesterol from the bloodstream.

Dosage and Administration:

• Recommended starting dose: 1–2 mg once daily, with or without food

• The dose may be adjusted up to a maximum of 4 mg/day depending on response and tolerance

• Monitor lipid levels periodically

Warnings and Precautions:

• Contraindicated in active liver disease and during pregnancy or breastfeeding

• Use with caution in patients with renal impairment, history of muscle disorders, or high alcohol intake

• Monitor liver enzymes and creatine kinase (CK) if muscle symptoms occur

Side Effects:
Common: myalgia, back pain, constipation, diarrhea, headache
Rare but serious: rhabdomyolysis, liver enzyme elevations

Storage:
Store below 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.